Ab initio study of molecular properties of l-tyrosine.
Ab initio calculations
Electronic structure
Molecular descriptors
Molecular properties
l-Tyrosine
Journal
Journal of molecular modeling
ISSN: 0948-5023
Titre abrégé: J Mol Model
Pays: Germany
ID NLM: 9806569
Informations de publication
Date de publication:
13 Jul 2023
13 Jul 2023
Historique:
received:
28
05
2023
accepted:
03
07
2023
medline:
17
7
2023
pubmed:
14
7
2023
entrez:
13
7
2023
Statut:
epublish
Résumé
l-Tyrosine is a naturally occurring agent that acts as a precursor in biosynthesis of monoaminergic neurotransmitters in brain such as dopamine, adrenaline, noradrenaline, and hormones like thyroxine and triiodothyronine. While l-tyrosine in vacuo adopts the canonical aminoacid form with -NH The energetic data at the Hartree-Fock MO-LCAO-SCF method has been conducted using def2-TZVP basis set, and improved by the many-body perturbation theory using the MP2 correction to the correlation energy. For the aminoacid form and the zwitterionic form of l-tyrosine, a set of molecular descriptors has been evaluated (ionization energy, electron affinity, molecular electronegativity, chemical hardness, electrophilicity index, dipole moment, quadrupole moment, and dipole polarizability). The solvent effect (CPCM) is very expressive to the zwitterionic form and alters the sign of the electron affinity from positive to negative values. In parallel, density-functional theory with B3LYP variant in the same basis set has been employed for full geometry optimization of the neutral and ionized forms of l-tyrosine allowing assessing the adiabatic (a) ionization/affinity processes. The complete vibrational analysis enables evaluating thermodynamic functions such as the inner energy, enthalpy, entropy, Gibbs energy, and consequently the absolute oxidation and reduction potentials. Of applied methods, the most reliable are B3LYP(a) results that account to the correlation energy and the electron and nuclear relaxation during the ionization/affinity processes.
Identifiants
pubmed: 37442864
doi: 10.1007/s00894-023-05648-8
pii: 10.1007/s00894-023-05648-8
pmc: PMC10344843
doi:
Substances chimiques
Tyrosine
42HK56048U
Amines
0
Amino Acids
0
Norepinephrine
X4W3ENH1CV
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
245Subventions
Organisme : Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
ID : VEGA 1/0191/22
Informations de copyright
© 2023. The Author(s).
Références
J Phys Chem A. 2023 Apr 27;127(16):3648-3657
pubmed: 37052318
Pharmacol Biochem Behav. 2015 Jun;133:1-6
pubmed: 25797188
Oncogene. 1997 Feb 20;14(7):773-82
pubmed: 9047384
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14707-12
pubmed: 14657361
J Chem Theory Comput. 2005 Jan;1(1):70-7
pubmed: 26641117
Front Behav Neurosci. 2013 Dec 16;7:200
pubmed: 24379768
J Inherit Metab Dis. 2016 Jul;39(4):483-8
pubmed: 27271695
J Clin Endocrinol Metab. 1983 Oct;57(4):760-3
pubmed: 6885965
JIMD Rep. 2022 Mar 17;63(3):221-230
pubmed: 35433173
J Chem Phys. 2020 Jun 14;152(22):224108
pubmed: 32534543
Environ Health Perspect. 1985 Sep;61:191-202
pubmed: 2866089
Physiol Behav. 2007 Nov 23;92(4):575-82
pubmed: 17585971
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2016 Apr;72(Pt 2):171-9
pubmed: 27048719
Physiol Behav. 2007 Feb 28;90(2-3):301-7
pubmed: 17078981
Lancet Diabetes Endocrinol. 2020 Sep;8(9):762-772
pubmed: 32822600
Molecules. 2018 May 26;23(6):
pubmed: 29861432